NCT07618260 2026-06-01SIM0613-101Jiangsu Simcere Pharmaceutical Co., Ltd.Phase 1 Recruiting294 enrolled
NCT07607678 2026-05-29A Study in People With Advanced Cancer to Test How Well Different Doses of BI 3819026 Are Tolerated When Taken Alone and Together With EzabenlimabBoehringer IngelheimPhase 1 Recruiting60 enrolled